Loading…
The endocannabinoid system’s genetic polymorphisms in sickle cell anemia patients
Sickle cell anemia (SCA) is a monogenic blood disease with complex and multifactorial pathophysiology. The endocannabinoid system (ECS) could be a candidate for modulating SCA complications, such as priapism, as it has demonstrated an essential role in hematopoiesis, platelet aggregation, and immune...
Saved in:
Published in: | Scientific reports 2024-12, Vol.14 (1), p.31562-9, Article 31562 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Sickle cell anemia (SCA) is a monogenic blood disease with complex and multifactorial pathophysiology. The endocannabinoid system (ECS) could be a candidate for modulating SCA complications, such as priapism, as it has demonstrated an essential role in hematopoiesis, platelet aggregation, and immune responses. We evaluated the association of ECS-related single nucleotide polymorphisms (SNP) (
FAAH
rs324420,
MAGL
rs604300,
CNR1
rs7766029, and
CNR2
rs35761398) with priapism in a Brazilian SCA cohort. The study involved 138 SCA patients (
n
= 80 with priapism and
n
= 58 without priapism). SCA was detected with HPLC, and the Hb SS genotype was confirmed with PCR-RE. Alpha thalassemia mutations were detected with Multiplex-PCR, and SNP genotyping was performed using TaqMan genotyping assays. We observed a lower frequency of -α
3.7kb
-thalassemia mutation in patients with priapism than in patients without this complication (
p
|
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-024-76480-0 |